{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:31:22Z","timestamp":1782405082645,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.critrevonc.2023.104227","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T15:41:27Z","timestamp":1705160487000},"page":"104227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review"],"prefix":"10.1016","volume":"194","author":[{"given":"Cong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.critrevonc.2023.104227_bib1","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/annonc\/mdw417","article-title":"Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF\/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy","volume":"27","author":"Ahmed","year":"2016","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104227_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ijrobp.2016.01.038","article-title":"Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: consensus guidelines from the eastern cooperative oncology group (ECOG)","volume":"95","author":"Anker","year":"2016","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104227_bib3","first-page":"153","article-title":"Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions","volume":"29","author":"Bernstein","year":"2014","journal-title":"Cancer Biother Radio."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104227_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081857","article-title":"Ipilimumab and stereotactic radiosurgery with CyberKnife(\u00ae) system in melanoma brain metastases: a retrospective monoinstitutional experience","volume":"13","author":"Borzillo","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.critrevonc.2023.104227_bib5","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1200\/JCO.2005.07.144","article-title":"Use of magnetic resonance imaging to assess blood-brain\/blood-glioma barrier opening during conformal radiotherapy","volume":"23","author":"Cao","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"26","key":"10.1016\/j.critrevonc.2023.104227_bib6","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104227_bib7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ijrobp.2017.11.041","article-title":"Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma","volume":"100","author":"Chen","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104227_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3171\/2015.6.JNS142763","article-title":"Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?","volume":"125","author":"Colaco","year":"2016","journal-title":"J. Neurosurg."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104227_bib9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104227_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-018-2880-y","article-title":"Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity","volume":"139","author":"Diao","year":"2018","journal-title":"J. Neurooncol"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104227_bib11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3171\/2017.7.JNS171286","article-title":"Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects","volume":"129","author":"Diao","year":"2018","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104227_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijrobp.2017.01.201","article-title":"Brain metastasis velocity: a novel prognostic metric predictive of overall survival and freedom from whole-brain radiation therapy after distant brain failure following upfront radiosurgery alone","volume":"98","author":"Farris","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104227_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.2004.08.140","article-title":"Determinants of outcome in melanoma patients with cerebral metastases","volume":"22","author":"Fife","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.critrevonc.2023.104227_bib14","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and letrozole in advanced breast cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104227_bib15","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1586\/ern.12.111","article-title":"Melanoma brain metastasis: overview of current management and emerging targeted therapies","volume":"12","author":"Fonkem","year":"2012","journal-title":"Expert Rev. Neurother."},{"issue":"16","key":"10.1016\/j.critrevonc.2023.104227_bib16","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1016\/j.ejca.2012.05.016","article-title":"Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies","volume":"48","author":"Du Four","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104227_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2018.06.017","article-title":"Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: patterns of care and treatment outcomes","volume":"128","author":"Gabani","year":"2018","journal-title":"Radio. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104227_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.lungcan.2017.12.008","article-title":"Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases","volume":"116","author":"Gauvain","year":"2018","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104227_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/CMR.0000000000000429","article-title":"Clinical and radiological response of BRAF inhibition and MEK inhibition in patients with brain metastases from BRAF-mutated melanoma","volume":"28","author":"Geukes Foppen","year":"2018","journal-title":"Melanoma Res."},{"issue":"26","key":"10.1016\/j.critrevonc.2023.104227_bib20","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1056\/NEJMoa064320","article-title":"Lapatinib plus capecitabine for HER2-positive advanced breast cancer","volume":"355","author":"Geyer","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104227_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/2326-6066.CIR-13-0115","article-title":"An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer","volume":"1","author":"Golden","year":"2013","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.critrevonc.2023.104227_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2021.07.028","article-title":"Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases","volume":"156","author":"Hilbers","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"21","key":"10.1016\/j.critrevonc.2023.104227_bib23","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1056\/NEJMc1203984","article-title":"Abscopal effect in a patient with melanoma","volume":"366","author":"Hiniker","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104227_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104227_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/CAD.0000000000000497","article-title":"The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy","volume":"28","author":"Kaidar-Person","year":"2017","journal-title":"Anticancer Drugs"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104227_bib26","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.annonc.2020.07.004","article-title":"ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee","volume":"31","author":"Keilholz","year":"2020","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104227_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3171\/2017.1.JNS162797","article-title":"Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and\/or immune-based therapies on treatment outcome","volume":"129","author":"Kotecha","year":"2018","journal-title":"J. Neurosurg."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104227_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2023.104227_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2018.08.025","article-title":"Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: an international meta-analysis of individual patient data","volume":"130","author":"Lehrer","year":"2019","journal-title":"Radio. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104227_bib30","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1470-2045(12)70431-X","article-title":"Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial","volume":"13","author":"Long","year":"2012","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.104227_bib31","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104227_bib32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jamaoncol.2017.3993","article-title":"Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation","volume":"4","author":"Martin","year":"2018","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104227_bib33","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/neuros\/nyy203","article-title":"BRAF V600 Mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study","volume":"84","author":"Mastorakos","year":"2019","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104227_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CMR.0b013e32835f3d90","article-title":"Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery","volume":"23","author":"Mathew","year":"2013","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104227_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0588-y","article-title":"Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity","volume":"7","author":"Minniti","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104227_bib36","first-page":"3427","article-title":"Patterned distribution of metastases from malignant melanoma in humans","volume":"43","author":"de la Monte","year":"1983","journal-title":"Cancer Res"},{"issue":"1-2","key":"10.1016\/j.critrevonc.2023.104227_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF01411440","article-title":"Early blood-brain barrier disruption after high-dose single-fraction irradiation in rats","volume":"136","author":"Nakata","year":"1995","journal-title":"Acta Neurochir. (Wien. )"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104227_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11060-013-1127-1","article-title":"Vemurafenib and radiation therapy in melanoma brain metastases","volume":"113","author":"Narayana","year":"2013","journal-title":"J. Neurooncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104227_bib39","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1158\/2326-6066.CIR-14-0138","article-title":"PD-1 restrains radiotherapy-induced abscopal effect","volume":"3","author":"Park","year":"2015","journal-title":"Cancer Immunol. Res"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104227_bib40","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/COC.0000000000000199","article-title":"Ipilimumab and stereotactic radiosurgery versus stereotactic radiosurgery alone for newly diagnosed melanoma brain metastases","volume":"40","author":"Patel","year":"2017","journal-title":"Am. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104227_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12029-011-9294-9","article-title":"A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management","volume":"43","author":"Postow","year":"2012","journal-title":"J. Gastrointest. Cancer"},{"issue":"19","key":"10.1016\/j.critrevonc.2023.104227_bib42","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/cncr.30138","article-title":"Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery","volume":"122","author":"Qian","year":"2016","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.critrevonc.2023.104227_bib43","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104227_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000763","article-title":"Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma","volume":"5","author":"Le Rhun","year":"2020","journal-title":"ESMO Open"},{"issue":"26","key":"10.1016\/j.critrevonc.2023.104227_bib45","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med"},{"issue":"21","key":"10.1016\/j.critrevonc.2023.104227_bib46","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/cncr.32375","article-title":"The impact of targeted therapies and immunotherapy in melanoma brain metastases: a systematic review and meta-analysis","volume":"125","author":"Rulli","year":"2019","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104227_bib47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nec.2020.06.001","article-title":"Epidemiology of brain metastases","volume":"31","author":"Sacks","year":"2020","journal-title":"Neurosurg. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104227_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3171\/jns.1998.88.1.0011","article-title":"Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma","volume":"88","author":"Sampson","year":"1998","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104227_bib49","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ijrobp.2003.12.037","article-title":"Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases","volume":"59","author":"Selek","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104227_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/107327480901600307","article-title":"Diagnosis and treatment of melanoma brain metastasis: a literature review","volume":"16","author":"Sloan","year":"2009","journal-title":"Cancer Control"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104227_bib51","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.bjc.6605622","article-title":"Determinants of survival in patients with brain metastases from cutaneous melanoma","volume":"102","author":"Staudt","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104227_bib52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104227_bib53","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1172\/JCI41911","article-title":"Trafficking of immune cells in the central nervous system","volume":"120","author":"Wilson","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104227_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11060-016-2072-6","article-title":"Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases","volume":"127","author":"Wolf","year":"2016","journal-title":"J. Neurooncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104227_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CMR.0000000000000538","article-title":"Incidence and prognosis of brain metastases in cutaneous melanoma patients: a population-based study","volume":"29","author":"Zhang","year":"2019","journal-title":"Melanoma Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104227_bib56","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/CMR.0000000000000682","article-title":"Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis","volume":"30","author":"Ziegler","year":"2020","journal-title":"Melanoma Res."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823003153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823003153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:55:44Z","timestamp":1760903744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823003153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":56,"alternative-id":["S1040842823003153"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104227","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104227"}}